|
New Delhi, Dec 07: The Serum Institute of India on Sunday became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for the Oxford COVID-19 vaccine in the country citing unmet medical needs due to the pandemic and in the interest of the public at large, official sources said.
Representational Image
A day earlier, the Indian arm of US pharmaceutical giant Pfizer became the first to seek a similar approval from India”s drug regulator for its own COVID-19 vaccine in the country, after securing such clearance in the UK and Bahrain.
The phase-three clinical trial of the Oxford COVID-19 vaccine, Covishield, is being conducted by the…
